Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 69

1.

Outcome After Myocardial Infarction Treated With Resolute Integrity and Promus Element Stents: Insights From the DUTCH PEERS (TWENTE II) Randomized Trial.

van Houwelingen KG, Lam MK, Löwik MM, Danse PW, Tjon Joe Gin RM, Jessurun GA, Anthonio RL, Sen H, Linssen GC, IJzerman MJ, Doggen CJ, von Birgelen C.

Rev Esp Cardiol (Engl Ed). 2016 Aug 29. pii: S1885-5857(16)30205-5. doi: 10.1016/j.rec.2016.05.029. [Epub ahead of print] English, Spanish.

PMID:
27595181
2.

An Ensemble Approach for Record Matching in Data Linkage.

Poon SK, Poon J, Lam MK, Yin Q, Sze DM, Wu JC, Mok VC, Ching JY, Chan KL, Cheung WH, Lau AY.

Stud Health Technol Inform. 2016;227:113-9.

PMID:
27440298
3.

DCE-MRI and IVIM-MRI of rabbit Vx2 tumors treated with MR-HIFU-induced mild hyperthermia.

Lam MK, Oerlemans C, Froeling M, Deckers R, Barten-Van Rijbroek AD, Viergever MA, Moonen CT, Bos C, Bartels LW.

J Ther Ultrasound. 2016 Mar 15;4:9. doi: 10.1186/s40349-016-0052-0. eCollection 2016.

4.

Long-term outcome and chest pain in patients with true versus non-true bifurcation lesions treated with second-generation drug-eluting stents in the TWENTE trial.

van Houwelingen KG, van der Heijden LC, Lam MK, Kok MM, Löwik MM, Louwerenburg JW, Linssen GC, IJzerman MJ, Doggen CJ, von Birgelen C.

Heart Vessels. 2016 Jan 8. [Epub ahead of print]

PMID:
26747438
5.

Tuning Toehold Length and Temperature to Achieve Rapid, Colorimetric Detection of DNA from the Disassembly of DNA-Gold Nanoparticle Aggregates.

Lam MK, Gadzikwa T, Nguyen T, Kausar A, Alladin-Mustan BS, Sikder MD, Gibbs-Davis JM.

Langmuir. 2016 Feb 16;32(6):1585-90. doi: 10.1021/acs.langmuir.5b03777. Epub 2016 Feb 2.

PMID:
26707736
6.

Patient preference regarding assessment of clinical follow-up after percutaneous coronary intervention: the PAPAYA study.

Kok MM, von Birgelen C, Lam MK, Löwik MM, van Houwelingen KG, Stoel MG, Louwerenburg JH, de Man FH, Hartmann M, Doggen CJ, van Til JA, IJzerman MJ.

EuroIntervention. 2016 Apr 20;11(13):1487-94. doi: 10.4244/EIJY15M10_06.

7.

Multi-gradient echo MR thermometry for monitoring of the near-field area during MR-guided high intensity focused ultrasound heating.

Lam MK, de Greef M, Bouwman JG, Moonen CT, Viergever MA, Bartels LW.

Phys Med Biol. 2015 Oct 7;60(19):7729-45.

PMID:
26394264
8.

The Functional Study of the N-Terminal Region of Influenza B Virus Nucleoprotein.

Liu M, Lam MK, Zhang Q, Elderfield R, Barclay WS, Shaw PC.

PLoS One. 2015 Sep 14;10(9):e0137802. doi: 10.1371/journal.pone.0137802. eCollection 2015.

9.

Value of the SYNTAX score for periprocedural myocardial infarction according to WHO and the third universal definition of myocardial infarction: insights from the TWENTE trial.

Tandjung K, Lam MK, Sen H, de Man FH, Louwerenburg JH, Stoel MG, van Houwelingen KG, Linssen GC, van der Palen J, Doggen CJ, von Birgelen C.

EuroIntervention. 2016 Jul 20;12(4):431-40. doi: 10.4244/EIJY15M08_01.

10.

Bifurcation treatment with novel, highly flexible drug-eluting coronary stents in all-comers: 2-year outcome in patients of the DUTCH PEERS trial.

van der Heijden LC, Kok MM, Lam MK, Danse PW, Schramm AR, Jessurun GA, Tjon Joe Gin RM, van Houwelingen KG, Hautvast RW, Linssen GC, Sen H, Löwik MM, IJzerman MJ, Doggen CJ, von Birgelen C.

Clin Res Cardiol. 2016 Mar;105(3):206-15. doi: 10.1007/s00392-015-0907-3. Epub 2015 Sep 2.

11.

Clinical Events and Patient-Reported Chest Pain in All-Comers Treated With Resolute Integrity and Promus Element Stents: 2-Year Follow-Up of the DUTCH PEERS (DUrable Polymer-Based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity) Randomized Trial (TWENTE II).

Sen H, Lam MK, Löwik MM, Danse PW, Jessurun GA, van Houwelingen KG, Anthonio RL, Tjon Joe Gin RM, Hautvast RW, Louwerenburg JH, de Man FH, Stoel MG, van der Heijden LC, Linssen GC, IJzerman MJ, Tandjung K, Doggen CJ, von Birgelen C.

JACC Cardiovasc Interv. 2015 Jun;8(7):889-99. doi: 10.1016/j.jcin.2015.01.033. Epub 2015 May 20.

12.

Quality of MR thermometry during palliative MR-guided high-intensity focused ultrasound (MR-HIFU) treatment of bone metastases.

Lam MK, Huisman M, Nijenhuis RJ, van den Bosch MA, Viergever MA, Moonen CT, Bartels LW.

J Ther Ultrasound. 2015 Mar 24;3:5. doi: 10.1186/s40349-015-0026-7. eCollection 2015.

13.

Fractional flow reserve and coronary bifurcation anatomy: a novel quantitative model to assess and report the stenosis severity of bifurcation lesions.

Tu S, Echavarria-Pinto M, von Birgelen C, Holm NR, Pyxaras SA, Kumsars I, Lam MK, Valkenburg I, Toth GG, Li Y, Escaned J, Wijns W, Reiber JH.

JACC Cardiovasc Interv. 2015 Apr 20;8(4):564-74. doi: 10.1016/j.jcin.2014.12.232. Epub 2015 Mar 26.

14.

Rat animal model for preclinical testing of microparticle urethral bulking agents.

Mann-Gow TK, Blaivas JG, King BJ, El-Ghannam A, Knabe C, Lam MK, Kida M, Sikavi CS, Plante MK, Krhut J, Zvara P.

Int J Urol. 2015 Apr;22(4):416-20. doi: 10.1111/iju.12693. Epub 2015 Jan 12.

15.

Three-year clinical outcome of patients with bifurcation treatment with second-generation Resolute and Xience V stents in the randomized TWENTE trial.

Lam MK, Sen H, van Houwelingen KG, Löwik MM, van der Heijden LC, Kok MM, de Man FH, Linssen GC, Tandjung K, Doggen CJ, von Birgelen C.

Am Heart J. 2015 Jan;169(1):69-77. doi: 10.1016/j.ahj.2014.10.011. Epub 2014 Oct 25.

PMID:
25497250
16.

Three-year clinical outcome after treatment of chronic total occlusions with second-generation drug-eluting stents in the TWENTE trial.

van Houwelingen KG, Sen H, Lam MK, Tandjung K, Löwik MM, de Man FH, Louwerenburg JH, Stoel MG, Hartmann M, Linssen GC, Doggen CJ, von Birgelen C.

Catheter Cardiovasc Interv. 2015 Feb 15;85(3):E76-82. doi: 10.1002/ccd.25713. Epub 2014 Nov 1.

PMID:
25339110
17.

Clinical outcome following second-generation drug-eluting stent use for off-label versus on-label indications: insights from the two-year outcome of the TWENTE trial.

Sen H, Lam MK, Tandjung K, Basalus MW, de Man FH, Louwerenburg JH, Stoel MG, van Houwelingen GK, Löwik MM, Linssen GC, Saïd SA, Nienhuis MB, Verhorst PM, van der Palen J, von Birgelen C.

EuroIntervention. 2014 Oct;10(6):664-71. doi: 10.4244/EIJV10I6A117.

18.

Feasibility of volumetric MRI-guided high intensity focused ultrasound (MR-HIFU) for painful bone metastases.

Huisman M, Lam MK, Bartels LW, Nijenhuis RJ, Moonen CT, Knuttel FM, Verkooijen HM, van Vulpen M, van den Bosch MA.

J Ther Ultrasound. 2014 Oct 10;2:16. doi: 10.1186/2050-5736-2-16. eCollection 2014.

19.

Coronary bifurcations: still the touchstone of drug-eluting stents and bioresorbable vascular scaffolds?

von Birgelen C, van Houwelingen KG, Lam MK.

Rev Esp Cardiol (Engl Ed). 2014 Oct;67(10):787-9. doi: 10.1016/j.rec.2014.05.005. Epub 2014 Aug 1. No abstract available.

PMID:
25262123
20.

Impact of previous coronary artery bypass surgery on clinical outcome after percutaneous interventions with second generation drug-eluting stents in TWENTE trial and non-enrolled TWENTE registry.

Sen H, Lam MK, Tandjung K, Löwik MM, van Houwelingen KG, Stoel MG, Louwerenburg HW, de Man FH, Linssen GC, Grandjean JG, Doggen CJ, von Birgelen C.

Int J Cardiol. 2014 Oct 20;176(3):885-90. doi: 10.1016/j.ijcard.2014.08.036. Epub 2014 Aug 13.

Items per page

Supplemental Content

Write to the Help Desk